This topic contains a solution. Click here to go to the answer

Author Question: The client is receiving warfarin (Coumadin). Which laboratory result will the nurse monitor to ... (Read 90 times)

arivle123

  • Hero Member
  • *****
  • Posts: 569
The client is receiving warfarin (Coumadin). Which laboratory result will the nurse monitor to evaluate the therapeutic response?
 
  1. WBC
  2. PT and INR
  3. BNP
  4. aPTT

Question 2

The client is receiving heparin (Hep-Lock). The nurse will monitor which laboratory results to evaluate therapeutic response?
 
  1. INR
  2. aPTT
  3. BNP
  4. PT



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

izzat

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

2

Rationale 1: WBC is used to determine infection.
Rationale 2: PT and INR should be monitored for a client receiving warfarin (Coumadin) therapy.
Rationale 3:BNP is incorrect because this lab result does not pertain to clotting.
Rationale 4:aPTT is incorrect because this should be monitored for a client receiving heparin therapy.

Global Rationale: PT and INR should be monitored for a client receiving warfarin (Coumadin) therapy. PT is incorrect because it should be monitored with INR for a client receiving warfarin (Coumadin) therapy. BNP is incorrect because this lab result does not pertain to clotting. aPTT is incorrect because this should be monitored for a client receiving heparin therapy.

Answer to Question 2

2

Rationale 1:INR is incorrect because it should be monitored for a client receiving warfarin (Coumadin) therapy.
Rationale 2: To avoid serious adverse effects, drug therapy with coagulation-modifier drugs is individualized to each patient and must be carefully monitored. For heparin, the activated partial thromboplastin time (aPTT) is used.
Rationale 3: BNP or beta natriuretic peptide is used for the severity rate of congestive heart failure.
Rationale 4:PT is incorrect because it should be monitored for a client receiving warfarin (Coumadin) therapy.

Global Rationale: To avoid serious adverse effects, drug therapy with coagulation-modifier drugs is individualized to each patient, and must be carefully monitored. For heparin, the activated partial thromboplastin time (aPTT) is used. PT and INRare incorrect because they should be monitored for a client receiving warfarin (Coumadin) therapy. BNP is incorrect because this lab result does not pertain to clotting.




arivle123

  • Member
  • Posts: 569
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


jojobee318

  • Member
  • Posts: 298
Reply 3 on: Yesterday
Gracias!

 

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library